Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.15B |
| 2 |
Tesla
TSLA
|
+$1.26B |
| 3 |
Vanguard FTSE Europe ETF
VGK
|
+$610M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$482M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$461M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$667M |
| 2 |
iShares Floating Rate Bond ETF
FLOT
|
+$652M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 4 |
Meta Platforms (Facebook)
META
|
+$583M |
| 5 |
iShares MSCI United Kingdom ETF
EWU
|
+$507M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.96% |
| 2 | Consumer Discretionary | 3.1% |
| 3 | Financials | 1.5% |
| 4 | Healthcare | 1.15% |
| 5 | Communication Services | 1.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NETI
7826
CALL
DELISTED
Eneti Inc.
NETI
| $125K | ﹤0.01% |
+10,300
| New | +$100K |
|
7827
Accuray
ARAY
$34M
| $124K | ﹤0.01% |
32,109
-380,127
| -92% | -$1.32M |
|
7828
KORU Medical Systems
KRMD
$164M
| $124K | ﹤0.01% |
36,005
-12,107
| -25% | -$47.5K |
|
7829
CALL
Aldeyra Therapeutics
ALDX
$93.5M
| $124K | ﹤0.01% |
+14,800
| New | +$146K |
|
7830
Senseonics Holdings Inc
SENS
$366M
| $124K | ﹤0.01% |
8,132
-1,790
| -18% | -$24.5K |
|
|
LX
7831
LexinFintech Holdings
LX
$241M
| $124K | ﹤0.01% |
54,072
-26,341
| -33% | -$63.9K |
|
7832
PUT
2x Long VIX Futures ETF
UVIX
$197M
| $124K | ﹤0.01% |
14
-12
| -46% | -$234K |
|
|
RPTX
7833
DELISTED
Repare Therapeutics
RPTX
| $123K | ﹤0.01% |
11,601
+833
| +8% | +$8.58K |
|
|
NETI
7834
PUT
DELISTED
Eneti Inc.
NETI
| $122K | ﹤0.01% |
+10,100
| New | +$98.5K |
|
|
RWT
7835
PUT
Redwood Trust
RWT
$594M
| $122K | ﹤0.01% |
19,200
-88,500
| -82% | -$553K |
|
|
POTX
7836
DELISTED
Global X Cannabis ETF
POTX
| $122K | ﹤0.01% |
19,084
-46,357
| -71% | -$366K |
|
|
INFN
7837
PUT
DELISTED
Infinera Corporation Common Stock
INFN
| $122K | ﹤0.01% |
25,200
-1,400
| -5% | -$7.7K |
|
7838
LifeMD
LFMD
$172M
| $121K | ﹤0.01% |
27,921
-13,579
| -33% | -$30.2K |
|
7839
TransAlta
TAC
$3.93B
| $121K | ﹤0.01% |
12,935
+252
| +2% | +$2.37K |
|
7840
CALL
Petco
WOOF
$794M
| $121K | ﹤0.01% |
13,600
-25,900
| -66% | -$238K |
|
|
EVA
7841
PUT
DELISTED
Enviva Inc.
EVA
| $120K | ﹤0.01% |
11,100
-5,700
| -34% | -$83K |
|
|
NIU
7842
Niu Technologies
NIU
$193M
| $120K | ﹤0.01% |
30,258
+18,592
| +159% | +$71.9K |
|
|
TDAY
7843
CALL
USA Today Co
TDAY
$1.06B
| $120K | ﹤0.01% |
+53,500
| New | +$107K |
|
7844
Aterian
ATER
$5.37M
| $120K | ﹤0.01% |
+21,721
| New | +$169K |
|
7845
PUT
PDS Biotechnology
PDSB
$43.4M
| $120K | ﹤0.01% |
+23,800
| New | +$156K |
|
|
EXK
7846
CALL
Endeavour Silver
EXK
$2.83B
| $120K | ﹤0.01% |
41,400
+18,300
| +79% | +$64.7K |
|
7847
Edgewise Therapeutics
EWTX
$4.68B
| $120K | ﹤0.01% |
15,438
-16,215
| -51% | -$137K |
|
7848
Heritage Insurance Holdings
HRTG
$991M
| $120K | ﹤0.01% |
31,070
-6,712
| -18% | -$26.9K |
|
|
CIM
7849
PUT
Chimera Investment
CIM
$1B
| $119K | ﹤0.01% |
6,900
-4,567
| -40% | -$72.7K |
|
|
AMRS
7850
DELISTED
Amyris Inc.
AMRS
| $119K | ﹤0.01% |
115,895
+6,843
| +6% | +$6.37K |
|
Similar funds
Jane Street's Q2 2023 Portfolio in Review
As of Q2 2023, Jane Street held 10,215 positions worth $297B, up 22% from $244B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Jane Street deployed $26.9B of net new capital in Q2 2023, opening 1,302 new positions and adding to 3,894 existing holdings. Its largest new stake was Kenvue: 10,291,011 shares worth $272M.
By sector, the portfolio is most concentrated in Technology at 4% of assets, up from 2.5% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $667M trimmed.
- Jane Street's largest Q2 2023 buy was Kenvue: 10,291,011 shares worth $272M.
- Jane Street added most to Apple in Q2 2023, an estimated $2.15B increase.
- Jane Street's biggest Q2 2023 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $667M.
- Jane Street fully exited JPMorgan BetaBuilders Europe ETF in Q2 2023, selling an estimated $325M.
- Jane Street's ten largest holdings make up 36% of its $297B portfolio in Q2 2023.
- Jane Street opened 1,302 new positions and closed 1,631 in Q2 2023.
- Jane Street's portfolio value rose 22% quarter-over-quarter to $297B.
Based on Jane Street's 13F filing for Q2 2023, filed 14 Aug 2023.